Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital
BIOGRAPHY
JUN 10, 2016 8:00 AM PDT
Lupus Anticoagulant (LA): Choosing the Right Testing Strategy for Your Laboratory
Presented at:
Stago EdVantage Virtual University
Speaker
Abstract
Lupus anticoagulants are markers of prothrombotic potential which may be indicative of underlying antiphospholipid syndrome (aPS) requiring treatment with ongoing anticoagulants. The purpose of this educational program is to update healthcare professionals regarding advancements in Lupus Anticoagulant (LA) testing. Current LA diagnostic guidelines, clinical evidence regarding LA significance, assay selection, and anticoagulant drugs interfering with LA testing will be discussed, along with clinical cases of high interest.
- Describe role of Lupus Anticoagulant (LA) in Antiphospholipid Syndrome (APS).
- Define current ISTH and CLSI Guidelines, identify tests, and define patient selection for appropriate LA work up.
- Recognize medications that may cause false positive LA results.
- Evaluate the right testing strategy for LA testing.
- Correlate LA and APS to specific clinical cases.
P.A.C.E. ® Credits are no longer available for this webinar.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...